Swiss National Science Foundation
OrganisationROR
Trials
Collaborator, Phase 2, Recruiting, 75 people, 11 Dec 2023
Collaborator, Phase 1, Withdrawn, 0 people, 21 Feb 2023
Collaborator, Phase 1/2, Recruiting, 120 people, 23 Dec 2022
Collaborator, Phase 4, Terminated, 7 people, 22 Oct 2021
Collaborator, Phase 2, Completed, 26 people, 29 Dec 2020
Collaborator, Phase 3, Completed, 116 people, 12 Aug 2020
Collaborator, Phase 3, Status unknown, 620 people, 23 May 2019
Collaborator, Phase 3, Completed, 257 people, 25 May 2017
Collaborator, Phase 4, Recruiting, 530 people, 15 May 2017
Collaborator, Phase 3, Terminated, 91 people, 17 Apr 2015
Collaborator, Phase 2, Terminated, 256 people, 5 Nov 2013
Collaborator, Phase 4, Terminated, 4 people, 12 Sept 2012
Collaborator, Phase 1, Completed, 160 people, 9 May 2012
Collaborator, Phase 1/2, Completed, 150 people, 9 Feb 2012
Collaborator, Phase 1/2, Completed, 46 people, 1 Sept 2008
Collaborator, Phase 1/2, Status unknown, 80 people, 15 Sept 2005
Phase 3, Status unknown, 204 people, 23 Aug 2005
Awards made
Ambizione, Evolution of senescence and sexual strategies in modular organisms, 232857, 2026–2030, 1 Sept 2026
Ambizione, Evolution of senescence and sexual strategies in modular organisms, 232857, CHF 857.3k, 2026–2030, 1 Sept 2026
Postdoc.Mobility, Health Inequalities over the Later Life Course: Does Income Inequality and Welfare State Matter?, 225502, 2026–2028, 1 Jun 2026
Project funding, Development of an in situ strategy for articular cartilage repair through nasal chondrocytes-inspired regenerative molecules, 10005979, 2026–2030, 1 May 2026
Project funding, Development of an in situ strategy for articular cartilage repair through nasal chondrocytes-inspired regenerative molecules, 10005979, CHF 999.7k, 2026–2030, 1 May 2026
Bilateral programmes, Comprehensive research on inflammation and aging with a focus on the role of cGAS-STING in inflammation-inducing cells., 238784, 2026–2030, 1 Mar 2026
École Polytechnique Fédérale de Lausanne
Bilateral programmes, Comprehensive research on inflammation and aging with a focus on the role of cGAS-STING in inflammation-inducing cells., 238784, CHF 624.6k, 2026–2030, 1 Mar 2026
Bilateral programmes, From Sleep Dynamics to Inflammaging Control: A High-Throughput Systems Biology Initiative for Brain Aging, 238772, 2026–2030, 1 Mar 2026
University of Geneva, Switzerland
Bilateral programmes, From Sleep Dynamics to Inflammaging Control: A High-Throughput Systems Biology Initiative for Brain Aging, 238772, CHF 625k, 2026–2030, 1 Mar 2026
Return CH Postdoc.Mobility, Investigating the role of mouse small noncoding RNAs in caloric restriction-dependent mitigation of ageing-related symptoms, 239413, 2026–2027, 1 Mar 2026
Return CH Postdoc.Mobility, Investigating the role of mouse small noncoding RNAs in caloric restriction-dependent mitigation of ageing-related symptoms, 239413, CHF 119.7k, 2026–2027, 1 Mar 2026
COST (European Cooperation in Science and Technology), Resolving mechanisms of aging heterogeneity by longitudinal live imaging, 10006453, 2026–2030, 1 Feb 2026
COST (European Cooperation in Science and Technology), Resolving mechanisms of aging heterogeneity by longitudinal live imaging, 10006453, CHF 399.2k, 2026–2030, 1 Feb 2026
Project funding, Clarifying the neurocognitive mechanisms of prospective memory through a working memory framework, 10004795, 2026–2029, 1 Jan 2026
University of Geneva, Switzerland
Project funding, Clarifying the neurocognitive mechanisms of prospective memory through a working memory framework, 10004795, CHF 644.9k, 2026–2029, 1 Jan 2026
Project funding, FLAME (Fair, Lightweight, Affordable, Multimodal, and Explainable) Machine Learning Methods for Predicting Alzheimer’s Disease Using Personalized and Adaptive Multimodal Biomarkers, 10006845, 2026–2029, 1 Jan 2026
Project funding, FLAME (Fair, Lightweight, Affordable, Multimodal, and Explainable) Machine Learning Methods for Predicting Alzheimer’s Disease Using Personalized and Adaptive Multimodal Biomarkers, 10006845, CHF 491.8k, 2026–2029, 1 Jan 2026
Spark, Early cancer detection using cell-free RNA in blood, 237816, 2026, 1 Jan 2026
Bridge - Discovery, Family Gene Toolkit: A digital service to support genetic care in Europe, 237643, 2026–2029, 1 Jan 2026
Bridge - Discovery, Family Gene Toolkit: A digital service to support genetic care in Europe, 237643, CHF 1.6m, 2026–2029, 1 Jan 2026
Sources: openalex.org
Funded papers
Design and model choices shape inference of age-varying genetic effects on complex traits
#315230-219587, 6 Oct 2026
10000207, 6 Oct 2026
PZ00P3_208999, 1 Oct 2026
211431, 28 Sept 2026
208205, 18 Sept 2026
10 Sept 2026
32003B_197687, 9 Sept 2026
The Proteasome Safeguards Red Blood Cell Integrity During Storage and After Transfusion
10.003.077, 9 Sept 2026
33CSCO-122661, 33CS30-139468, 33CS30-148401, 33CS30_177535, 3247730_204523, 320030_207687, 4 Sept 2026
32003B_197687, 213769, 3 Sept 2026
The ventilatory response pattern to exercise across the age-span in healthy adults
182815, 1 Sept 2026
238010, 31 Aug 2026
Effects of strength and balance training on the structure of the aging brain
194260, 213769, 32003B_197687, 31 Aug 2026
Deep learning aging marker from retinal images unveils sex-specific clinical and genetic signatures
CRSII5 209510, 26 Aug 2026
Causal inference for multiple risk factors and diseases from genomics data
PCEGP3-181181, 25 Aug 2026
Childhood misfortunes and metabolic syndrome in old age: European prospective cohort study
51NF40-160590, 13 Aug 2026
219687, 1 Aug 2026
Sources: api.crossref.org
Named in competing interests
Grants or research support, 1 Oct 2026
Grants or research support, 4 Sept 2026
Grants or research support, 18 Aug 2026
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Insomnia with sleep apnea linked to higher cardiovascular risk
EClinicalMedicine, 11 Oct 2026